invasive pneumococcal disease epidemiology forecast insight

DelveInsight’s ‘Invasive Pneumococcal Disease – Epidemiology Forecast—2034’ report delivers an in-depth understanding of Invasive Pneumococcal Disease, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Invasive Pneumococcal Disease Disease Understanding

According to European Centre for Disease Prevention and Control (ECDC), pneumococcal diseases are symptomatic infections caused by the bacterium Streptococcus pneumoniae (S. pneumoniae), commonly referred to as pneumococci. The term Invasive Pneumococcal Disease is used for more severe and invasive pneumococcal infections, such as bacteremia, sepsis, meningitis, and osteomyelitis. The bacterium can be isolated from normally sterile sites. Pneumococcal infections and IPDs are major causes of infectious disease morbidity and mortality in Europe and globally, with the highest burden of disease found in young children and the elderly.

Invasive Pneumococcal Disease Epidemiology

The Invasive Pneumococcal Disease epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool, trends, and assumptions.

Key Findings

The total incident cases of Invasive Pneumococcal Disease patients are increasing in 7MM during the study period, i.e., 2021-2034.

The disease epidemiology covered in the report provides historical as well as forecasted Invasive Pneumococcal Disease symptoms epidemiology segmented as the Incidence of IPD, Age-specific Cases of IPD, Incidence by Clinical Presentation, and Vaccination Coverage. The report includes the incident scenario of Invasive Pneumococcal Disease symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country-wise Invasive Pneumococcal Disease Epidemiology

The epidemiology segment also provides the Invasive Pneumococcal Disease epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

• The incident cases of Invasive Pneumococcal Disease associated in 7MM countries were 55,105 in 2020.
• As per the estimates, the United States has the largest incident population of Invasive Pneumococcal Disease.
• Among the EU5 countries, France had the highest incident cases of Invasive Pneumococcal Disease, followed by the United Kingdom. On the other hand, Italy had the lowest incident cases with 1,549 cases in 2020.

Scope of the Report

• The Invasive Pneumococcal Disease report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
• The Invasive Pneumococcal Disease Epidemiology Report and Model provide an overview of Invasive Pneumococcal Disease ’s risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report provides insight into Invasive Pneumococcal Disease ’s a historical and forecasted patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Invasive Pneumococcal Disease.
• The report provides the segmentation of the Invasive Pneumococcal Disease epidemiology by the incidence of IPD in 7MM.
• The report provides the Invasive Pneumococcal Disease epidemiology segmentation by Age-specific Cases of IPD in 7MM.
• The report provides the Invasive Pneumococcal Disease epidemiology segmentation by Incidence by Clinical Presentation cases of IPD in 7MM.
• The report provides the Invasive Pneumococcal Disease epidemiology segmentation by Vaccination coverage in IPD in 7MM.

Report Highlights

• 10-year Forecast of Invasive Pneumococcal Disease epidemiology
• 7MM Coverage
• Incidence of IPD
• Age-specific Cases of IPD
• Incidence by Clinical Presentation
• Vaccination coverage

KOL Views

We interview KOLs, and SMEs’ opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM for the patient population about Invasive Pneumococcal Disease?
• What are the key findings of the Invasive Pneumococcal Disease epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2021-2034)?
• What would be the total number of Invasive Pneumococcal Disease patients across the 7MM during the forecast period (2021-2034)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2021-2034)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2021-2034)?
• What are the disease risk, burden, and unmet needs of Invasive Pneumococcal Disease?
• What are the currently available treatments for Invasive Pneumococcal Disease?

Reasons to buy

The Invasive Pneumococcal Disease epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Invasive Pneumococcal Disease market.
• Quantify patient populations in the global Invasive Pneumococcal Disease market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Invasive Pneumococcal Disease therapeutics in each of the markets covered.
• Understand the magnitude of the Invasive Pneumococcal Disease population by its incidence.
• Understand the magnitude of the Invasive Pneumococcal Disease population by its Age-specific cases.
• Understand the magnitude of the Invasive Pneumococcal Disease population by its incidence by clinical presentation.
• Understand the magnitude of the Invasive Pneumococcal Disease population by its vaccination coverage.
• The Invasive Pneumococcal Disease epidemiology report and model were written and developed by Masters and PhD level epidemiologists.
• The Invasive Pneumococcal Disease Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population